Cargando…

Ramosetron hydrochloride for the prevention of cancer chemotherapy induced nausea and vomiting: The Indian experience

BACKGROUND: Despite the advent of 5-HT(3) antagonists, control of delayed gastrointestinal adverse events with cancer chemotherapy is still not optimal. This open label, active controlled, multicentric clinical trial was undertaken to assess the comparative efficacy and safety of ramosetron with ond...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanmukhani, Jayesh J., Pawar, Prafulla, Mittal, Ravindra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	SOUTH ASIAN UPDATE: Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014645/ https://www.ncbi.nlm.nih.gov/pubmed/24818110 http://dx.doi.org/10.4103/2278-330X.130466

Ejemplares similares

Pediatric oncology services in Nepal
por: Sah, Kailash Prasad, et al.
Publicado: (2014)

Barriers for early detection of cancer amongst Indian rural women
por: Tripathi, Neha, et al.
Publicado: (2014)

The preventative effect of ramosetron on postoperative nausea and vomiting after total thyroidectomy
por: Lee, Dong Chul, et al.
Publicado: (2011)

Ramosetron for the prevention of postoperative nausea and vomiting (PONV): a meta-analysis
por: Kim, Won Oak, et al.
Publicado: (2011)

A retrospective study of clinico-pathological spectrum of carcinoma breast in a West Delhi, India
por: Nigam, Jitendra Singh, et al.
Publicado: (2014)

Breaking bad news of cancer diagnosis – Perception of the cancer patients in a rural community in Malaysia
por: Bain, Mathew Gabriel, et al.
Publicado: (2014)

Afro Middle East Asian symposium on cancer cooperation
por: Parikh, Purvish M., et al.
Publicado: (2014)

A Randomized, Double-Blind Pilot Study of Dose Comparison of Ramosetron to Prevent Chemotherapy-Induced Nausea and Vomiting
por: Kim, Ka-Rham, et al.
Publicado: (2015)

Comparison of ramosetron with ondansetron for the prevention of post-operative nausea and vomiting in high-risk patients
por: Agarkar, Sandip, et al.
Publicado: (2015)

Ramosetron versus ondansetron for postoperative nausea and vomiting in strabismus surgery patients
por: Joo, Jin, et al.
Publicado: (2016)

Comparison of Ramosetron Plus Dexamethasone with Ramosetron Alone on Postoperative Nausea, Vomiting, Shivering and Pain after Thyroid Surgery
por: Lee, Myeong Jong, et al.
Publicado: (2015)

The effect of palonosetron hydrochloride in the prevention of chemotherapy-induced moderate and severe nausea and vomiting
por: HUANG, JIAN, et al.
Publicado: (2013)

Multicenter nonrandomized trial of ramosetron versus palonosetron in controlling chemotherapy-induced nausea and vomiting for colorectal cancer
por: Kim, Jin Soo, et al.
Publicado: (2014)

Ramosetron versus Palonosetron in Combination with Aprepitant and Dexamethasone for the Control of Highly-Emetogenic Chemotherapy-Induced Nausea and Vomiting
por: Kang, Jin Hyoung, et al.
Publicado: (2020)

Effective Dose of Ramosetron for Prophylaxis of Postoperative Nausea and Vomiting in High-Risk Patients
por: Lee, Seongheon, et al.
Publicado: (2015)

Effects of Ramosetron on Nausea and Vomiting Following Spinal Surgery: A Meta-Analysis
por: Lin, Yiyun, et al.
Publicado: (2022)

Palonosetron and Ramosetron Compared for Effectiveness in Preventing Postoperative Nausea and Vomiting: A Systematic Review and Meta-Analysis
por: Ahn, EunJin, et al.
Publicado: (2016)

A Comparative Evaluation of Ramosetron with Ondansetron for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Urological Procedures
por: Mujoo, Samiullah, et al.
Publicado: (2017)

Efficacy of dexamethasone added to ramosetron for preventing postoperative nausea and vomiting in highly susceptible patients following spine surgery
por: Yang, So-Young, et al.
Publicado: (2012)

Efficacy of Palonosetron vs. Ramosetron for the Prevention of Postoperative Nausea and Vomiting: A Meta-Analysis of Randomized Controlled Trials
por: Kim, Min-Soo, et al.
Publicado: (2017)

Levosulpiride and Ramosetron for the Prevention of Postoperative Nausea and Vomiting in Laparoscopic Surgery: A Prospective Randomized Double-blind Study
por: Ranjithkumar, R. T., et al.
Publicado: (2022)

A Phase II Study to Evaluate the Efficacy of Ramosetron, Aprepitant, and Dexamethasone in Preventing Cisplatin-Induced Nausea and Vomiting in Chemotherapy-Naïve Cancer Patients
por: Jang, Geundoo, et al.
Publicado: (2013)

Dose-Ranging Study of Ramosetron for the Prevention of Nausea and Vomiting after Laparoscopic Gynecological Surgery: A Prospective Randomized Study
por: Cho, Jin Sun, et al.
Publicado: (2019)

Comparison of equipotent doses of Ramosetron, Ondansetron, and sub-hypnotic dose of Propofol for prevention of postoperative nausea and vomiting in laparoscopic cholecystectomy
por: Acharya, Shilpa Amol, et al.
Publicado: (2021)

The effect of aprepitant for the prevention of postoperative nausea and vomiting in patients undergoing gynecologic surgery with intravenous patient controlled analgesia using fentanyl: aprepitant plus ramosetron vs ramosetron alone
por: Lee, Se-Jin, et al.
Publicado: (2012)

Stability and Compatibility of Ramosetron with Midazolam in 0.9% Sodium Chloride Injection for Postoperative Nausea and Vomiting Administration
por: Xia, Jingsheng, et al.
Publicado: (2020)

Ondansetron, ramosetron, or palonosetron: Which is a better choice of antiemetic to prevent postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy?
por: Swaika, Sarbari, et al.
Publicado: (2011)

Comparison of palonosetron, granisetron, and ramosetron for the prevention of postoperative nausea and vomiting after laparoscopic gynecologic surgery: a prospective randomized trial
por: Lee, Won-Suk, et al.
Publicado: (2015)

Comparative efficacy of ramosetron and ondansetron in preventing postoperative nausea and vomiting: An updated systematic review and meta-analysis with trial sequential analysis
por: Yokoi, Ayako, et al.
Publicado: (2017)

Combination of gabapentin and ramosetron for the prevention of postoperative nausea and vomiting after gynecologic laparoscopic surgery: a prospective randomized comparative study
por: Kim, Kyung Mi, et al.
Publicado: (2017)

The effectiveness of ramosetron and ondansetron for preventing postoperative nausea and vomiting after arthroscopic rotator cuff repair: a randomized controlled trial
por: Lee, Sang-Uk, et al.
Publicado: (2020)

Comparison of the Effectiveness of Palonosetron and Ramosetron in Preventing Postoperative Nausea and Vomiting: Updated Systematic Review and Meta-Analysis with Trial Sequential Analysis
por: Kim, Hyo Jin, et al.
Publicado: (2022)

Overview of pediatric oncology and hematology in Myanmar
por: Halbert, Jay, et al.
Publicado: (2014)

Improving cancer care in Pakistan
por: Jamshed, Arif, et al.
Publicado: (2013)

Brief report on pediatric oncology in Bangladesh
por: Islam, Afiqul, et al.
Publicado: (2013)

Cancer care scenario in Bangladesh
por: Uddin, A. F. M. Kamal, et al.
Publicado: (2013)

Comprehensive update on cancer scenario of Bangladesh
por: Hussain, Syed Md Akram
Publicado: (2013)

Association of nefopam use with postoperative nausea and vomiting in gynecological patients receiving prophylactic ramosetron: A retrospective study
por: Park, Sun-Kyung, et al.
Publicado: (2018)

A randomized, double-blind study to evaluate the efficacy of ramosetron and palonosetron for prevention of postoperative nausea and vomiting after gynecological laparoscopic surgery
por: Park, Soo Kyoung, et al.
Publicado: (2013)

Scheduled injection of ramosetron for prevention of nausea and vomiting following single-port access total laparoscopic hysterectomy: a prospective randomized study
por: Li, Shoou-Chern, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ps7245qo91v1g7fluht8n1aee1